Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine
Clinical trial NCT04216888 · COMPLETED
Trial details
- NCT number
- NCT04216888
- Sponsor
- Dan Iosifescu
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-26
- Primary completion
- 2020-12-28
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.